Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients
暂无分享,去创建一个
R. Dierckx | J. Bartunek | M. Goethals | M. Vanderheyden | W. Heggermont | S. Verstreken | L. Delrue | K. Dierickx | Karen M. E. Dierickx
[1] C. Bara,et al. MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy , 2017, Transplantation.
[2] A. Yeung,et al. Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy. , 2016, Journal of the American College of Cardiology.
[3] Deepak L. Bhatt,et al. Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation. , 2016, Journal of the American College of Cardiology.
[4] S. Fichtlscherer,et al. Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics. , 2016, European heart journal.
[5] S. Fieuws,et al. Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[6] J. Rosenblat,et al. Therapeutic Angiogenesis by Ultrasound-Mediated MicroRNA-126-3p Delivery , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[7] L. Lerman,et al. Clinical Implications of Intracoronary Imaging in Cardiac Allograft Vasculopathy , 2015, Circulation. Cardiovascular imaging.
[8] S. Dimmeler,et al. MicroRNA-126 in atherosclerosis. , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[9] F. Kiessling,et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1 , 2014, Nature Medicine.
[10] T. Lehtimäki,et al. MicroRNAs in the atherosclerotic plaque. , 2013, Clinical chemistry.
[11] A. Schober,et al. Pathogenic arterial remodeling: the good and bad of microRNAs. , 2013, American journal of physiology. Heart and circulatory physiology.
[12] A. Schober,et al. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[13] A. Angelini,et al. Recent developments on coronary microvasculopathy after heart transplantation: a new target in the therapy of cardiac allograft vasculopathy. , 2012, Current vascular pharmacology.
[14] T. Lehtimäki,et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. , 2011, Atherosclerosis.
[15] Stefanie Dimmeler,et al. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[16] S. Fichtlscherer,et al. Transcoronary Concentration Gradients of Circulating MicroRNAs , 2011, Circulation.